Loading clinical trials...
Loading clinical trials...
Surgical resection is the most effective treatment of primary and secondary liver tumors. Technical innovations have mainly focused on minimizing bleeding during transection of the hepatic parenchyma ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Southwest Hospital, China
NCT06345547 · Sarcopenia, Cirrhosis, and more
NCT06902246 · Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma
NCT07069725 · Liver Fibrosis, Hepatic Cirrhosis
NCT07422753 · Hepatocellular Carcinoma (HCC)
NCT07175441 · Advanced Unresectable Hepatocellular Carcinoma
Institute of Hepatobiliry surgery,Southwest Hospital
Chongqing, Chongqing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions